Nanogel as a controlled drug delivery system

International Journal of Pharmaceutical Sciences Review and Research

Volumn 4, Issue 2, 2010, Pages 37-41

  Patel, Hitesh A ^a   Patel, Jayvadan K ^a  

^a NOOTAN PHARMACY COLLEGE   (India)

Author keywords

Hydrogel; Hydrogel nanoparticles; Nanogels; Nanoparticles; PEO; PVP; Sodium alginate

Indexed keywords

ALGINIC ACID; CHITOSAN; ETHAMBUTOL; ISONIAZID; MACROGOL; NANOPARTICLE; POLY(N ISOPROPYLACRYLAMIDE); POLYETHYLENEIMINE; POLYVINYL ALCOHOL; POVIDONE; PYRAZINAMIDE; RIFAMPICIN;

ARTICLE; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CONTROLLED DRUG RELEASE; CROSS LINKING; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMAN; HYDROGEL; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE;

EID: 79952029406     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. M. Patel, T. Shah, A. Amin. Therapeutic opportunities in colon-specific drug delivery systems. Crit Rev Ther Drug Syst. 24; 2007, 147-202.
2. Y. Kato, H. Onishi. Application of chitin and chitosan derivatives in the pharmaceutical field. Curr pharm Biotechnol. 4; 2003, 303-309.
3. T. G. Shutava, Y. M. Lvov. Nano-engineered microcapsulates of gtannic acid and chitosan for protein encapsulation. J Nanosci Nanotechnol. 6; 2006, 1655-1661.
4. J. Knapczyk, L. Krowczynski. Requirements of chitosan for pharmaceutical and biomedical applications.Elsevier,London.1989;657-663.
5. V. Dodane, D. Vilivalam. Pharmaceutical applications of chitosan. Pharm Sci Technol Today. 16; 1998, 246-253.
6. st century,S.T.P. Pharm Sci. 10; 2000, 5-22.
7. Y. Ohya, M. Shiratani. Release behaviour of 5- flurouracil from chitosan-gel nanospheres immobilizing 5-flurouracil coated with polysaccharides and theit cell specific cytotoxicity, pure Appl. Chem. 31;1994, 629-642.
8. Q. Gan, T. Wang. Modulation of surface charge, particles size and morphological properties of chitosan-TPP nanoparticless intended for gene delivery,colloids Surf. B Biointerfaces. 44;2005, 65-73.
9. R. Fernandez, P. Cavlo. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm Res. 16;1999, 1576-1581.
10. A. Berthold, K. Cremer. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium sodium phosphate as model for anti-inflammatory drugs. J Control Release. 39; 1996, 17-25.
11. K. Ray, H. Q. Mao. Oral immunization with DNA chitosan nanoparticles, Proc. Int Symp Control Release Mater. 26;1999, 348-349.
12. H. Tokumitsu, H. Ichikawa. Chitosan-gadopenteric acid complex nanoparticles for gadolinium neutron capture therapy of cancer:preparation by novel emulsion-droplet coalescence technique and characterization. Pharm Res. 16;1999, 1830-1835.
13. S. Mitra, U. Gaur. Tumor targeted delivery of encapsulated detxran-doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release. 74; 2001, 317-323.
14. S. Yu, J. Hu, X. Pan. Stable and pH sensitive nanogels prepared by self-assemly of chitosan and ovalbumin, Langmuir. 22; 2006, 2754-2759.
15. M. Rajaonarivony, C. Vauthier. Development of a new drug carrier made from alginate. J Pharm Sci. 82(9); 1993, 912-917.
16. Z. Ahmed, S. Sharma. Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int J Antimicrob Agents. 26(4); 2005, 298-303.
17. J. K. Li, N. Wang. Poly (vinyl alcohol) nanoparticles prepared by freezing-thawing process for protein/peptide drug delivery. J control Release. 56;1998, 117-126.
18. K. S. Soppimath, T. M. Aminabhavi. Biodegradable polymeric nanoparticles as drug delivery devices. J Control release. 70 (2); 2001, 1-20.
19. M. A. Breitenbach, W. Kamm. Oral and nasal administration od tetanus toxoid loaded nanoparticles consisting of novel charged biodegradable polyesters for mucosal vaccination, Proc. Intern Symp Control release Bioact mater. 26;1999, 348-349.
20. H. Vihola, A. Laukkane. Binding and release of drugs into and from thermosensitive poly (N-vinly caprolactam) nanoparticles. Eur J Pharm sci. 16 (2); 2002, 69-74.
21. T. K. Bronich, S. V. Vinogradov. Interaction of nanosized copolymer networks with oppositely charged amphiphilic molecules. Nano lett. 1; 2001, 535-540.
22. A. V. Kabanov. Taking polycation gene delivery systems from in vitro to in vivo. Pharm Sci Technol Today. 2;1999, 365-372.
23. P. J. Watts, M. C. Davies. Microencapsulation using emulsification/solvent evaporation: an overview of techniques and applications. Crit Rev Ther Drug Carr Syst. 7;1990, 235-259.
24. D. J. Bharali, S. K. Sahoo. Cross-linked polyvinyl pyrrolidone nanoparticles: a potential carrier for hydrophilic drugs. J Colloid Interface sci. 258; 2003, 415-423.
25. D. Guowei, K. Adriane. PVP magnetic nanospheres: biocompatibility, in vitro and in vivo bleomycin release. Int J Pharm. 328; 2006.
26. G. Huang, J. Gao. Controlled drug release from hydrogel nanoparticles networks. J Control Release. 94; 2004, 303-311.
27. D. Gan, L. A. Lyon. Tunable swelling kinetics in coreshell hydrogel nanoparticles. J Am Chem Soc. 123; 2001, 7511-7517.